ATE525064T1 - Pharmazeutische zusammensetzung mit desloratadin - Google Patents

Pharmazeutische zusammensetzung mit desloratadin

Info

Publication number
ATE525064T1
ATE525064T1 AT09008618T AT09008618T ATE525064T1 AT E525064 T1 ATE525064 T1 AT E525064T1 AT 09008618 T AT09008618 T AT 09008618T AT 09008618 T AT09008618 T AT 09008618T AT E525064 T1 ATE525064 T1 AT E525064T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
desloratadine
composition containing
pharmaceutically acceptable
present
Prior art date
Application number
AT09008618T
Other languages
English (en)
Inventor
Chaitanya Yogananda
Srinath Boddu
Bala Rallabandi
Manohar Pasahn
Ansgar Fitzner
Original Assignee
Tiefenbacher Alfred E Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tiefenbacher Alfred E Gmbh & Co Kg filed Critical Tiefenbacher Alfred E Gmbh & Co Kg
Application granted granted Critical
Publication of ATE525064T1 publication Critical patent/ATE525064T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
AT09008618T 2009-07-01 2009-07-01 Pharmazeutische zusammensetzung mit desloratadin ATE525064T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09008618A EP2269586B1 (de) 2009-07-01 2009-07-01 Pharmazeutische Zusammensetzung mit Desloratadin

Publications (1)

Publication Number Publication Date
ATE525064T1 true ATE525064T1 (de) 2011-10-15

Family

ID=41090304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09008618T ATE525064T1 (de) 2009-07-01 2009-07-01 Pharmazeutische zusammensetzung mit desloratadin

Country Status (3)

Country Link
EP (1) EP2269586B1 (de)
AT (1) ATE525064T1 (de)
WO (1) WO2011000518A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2568970T (pt) * 2010-05-10 2019-02-11 Lesvi Laboratorios Sl Formulações farmacêuticas estáveis contendo um anti-histamínico
RU2550958C2 (ru) * 2013-04-23 2015-05-20 Общество с ограниченной ответственностью "Трейдсервис" Лекарственная форма, содержащая дезлоратадин и способ ее изготовления
RU2537169C1 (ru) * 2013-06-18 2014-12-27 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция, содержащая дезлоратадин (варианты)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570306B2 (en) 1984-02-15 1988-03-10 Schering Corporation 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts.
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
PE71699A1 (es) 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra
UA62976C2 (en) 1997-07-02 2004-01-15 Schering Corp Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
CZ300843B6 (cs) 1998-07-10 2009-08-26 Schering Corporation Stabilizovaný farmaceutický prostredek na bázi dekarbonylethoxyloratadinu
US20040258752A1 (en) * 2003-01-31 2004-12-23 Paruthi Manoj Kumar Taste masking pharmaceutical composition and process for its preparation
CN1245975C (zh) 2003-05-28 2006-03-22 天津药物研究院 一种使地洛他定在制剂中稳定的药物组合物
EP1728513A3 (de) 2005-05-20 2007-10-31 Dr. Reddy's Laboratories, Inc. Stabile Zusammensetzungen von Desloratadine
US20080118555A1 (en) 2005-10-20 2008-05-22 Glenmark Pharmaceuticals Limited Stable pharmaceutical composition containing desloratadine
WO2007096733A2 (en) 2006-02-22 2007-08-30 Orchid Chemicals & Pharmaceuticals Limited Desloratadine-containing formulation stabilized with cyclodextrin
WO2007140987A1 (en) 2006-06-07 2007-12-13 Sandoz Ag Stable and bioavailable formulations and a novel form of desloratadine
US20100303908A1 (en) 2007-05-11 2010-12-02 Balamurugan Jeganathan Pharmaceutical composition comprising desloratadine

Also Published As

Publication number Publication date
EP2269586B1 (de) 2011-09-21
EP2269586A1 (de) 2011-01-05
WO2011000518A1 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
MY174002A (en) Combination theraphy for the treatment of diabetes
EA201100305A1 (ru) Лечение респираторных заболеваний
UA94390C2 (ru) Применение производных индолинонов, предназначенных для лечения или предупреждения идиопатического фиброза легких
MD4736C1 (ro) Compus policiclic de carbamoilpiridonă şi utilizarea farmaceutică a acestuia
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
EA202091303A3 (ru) Композиция ингибитора jak для местного применения
GEP20156366B (en) Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
EA201291410A1 (ru) Фармацевтические композиции, содержащие 4-амино-5-фтор-3-[6-(4-метилпиперазин-1-ил)-1h-бензимидазол-2-ил]-1h-хинолин-2-она лактат моногидрат
UA105229C2 (uk) Фармацевтичний склад
UA109421C2 (uk) Фармацевтична композиція, яка містить ліганди сигма-рецептора
MX2009001660A (es) Compuestos de 2,5-dihidroxibenceno para el tratamiento de psoriasis.
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
MX2013004162A (es) Composiciones farmaceuticas que contienen un inhibidor de dgat1.
RS54244B1 (en) NALBUFINE BASED FORMULATIONS AND THEIR USE
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
WO2012087255A3 (en) Pharmaceutical formulations comprising imatinib
IN2012DN02502A (de)
BR112014000195A2 (pt) formulações de darunavir
MX2009011999A (es) Extruidos con enmascaramiento del sabor mejorado.
DK2244703T3 (da) Lægemiddel og fremstillingen og anvendelse deraf i behandlingen af smertefulde neuropatier
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
PH12015500012B1 (en) Benzodioxole derivative and preparation method and use thereof
NO20070522L (no) Oral vedvarende frigivelsesformulering av tedisamil med gastriske bibeholdelsesegenskaper
ATE525064T1 (de) Pharmazeutische zusammensetzung mit desloratadin
MX2012002209A (es) Formulaciones de liberacion controlada de compuestos de anabaseina y usos de los mismos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties